{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:18:05Z","timestamp":1792124285503,"version":"4.4.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":58,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Korea Health Technology R&D Project through the Korea Health Industry Development Institute","award":["RS-2024-00439029"],"award-info":[{"award-number":["RS-2024-00439029"]}]},{"name":"National Research Foundation of Korea (NRF) funded by the Korea government,","award":["MSIT (RS-2023-00217317)"],"award-info":[{"award-number":["MSIT (RS-2023-00217317)"]}]},{"name":"Chonnam National University Hospital Biomedical Research Institute","award":["BCRI26034"],"award-info":[{"award-number":["BCRI26034"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04451-w","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:44:21Z","timestamp":1778575461000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Multiscale molecular modeling\u2013directed ROS-responsive nanotherapy for dual-axis regulation of fibrotic and inflammatory signaling in alport nephropathy"],"prefix":"10.1186","volume":"24","author":[{"given":"Hong Sang","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aravindkumar","family":"Sundaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arathy","family":"Vasukutty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansuja Pulikkal","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padmanaban","family":"Sathiyamoorthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Heon","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Seong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Kwon","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Wan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In-Kyu","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Hui","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"4451_CR1","doi-asserted-by":"publisher","first-page":"6165","DOI":"10.1021\/acsnano.2c12140","volume":"17","author":"N Trac","year":"2023","unstructured":"Trac N, Ashraf A, Giblin J, Prakash S, Mitragotri S, Chung EJ. Spotlight on genetic kidney diseases: A call for drug delivery and nanomedicine solutions. ACS Nano. 2023;17:6165\u201377.","journal-title":"ACS Nano"},{"key":"4451_CR2","doi-asserted-by":"publisher","first-page":"848389","DOI":"10.3389\/fmed.2022.848389","volume":"9","author":"E Chavez","year":"2022","unstructured":"Chavez E, Rodriguez J, Drexler Y, Fornoni A. Novel therapies for Alport syndrome. Front Med. 2022;9:848389.","journal-title":"Front Med"},{"key":"4451_CR3","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1053\/j.ajkd.2020.03.026","volume":"77","author":"CE Kashtan","year":"2021","unstructured":"Kashtan CE. Alport syndrome: achieving early diagnosis and treatment. Am J Kidney Dis. 2021;77:272\u20139.","journal-title":"Am J Kidney Dis"},{"key":"4451_CR4","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1042\/CS20191276","volume":"134","author":"H Mabillard","year":"2020","unstructured":"Mabillard H, Sayer JA. SGLT2 inhibitors\u2013a potential treatment for Alport syndrome. Clin Sci. 2020;134:379\u201388.","journal-title":"Clin Sci"},{"key":"4451_CR5","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1093\/ndt\/gfz131","volume":"34","author":"R Torra","year":"2019","unstructured":"Torra R, Furlano M. New therapeutic options for Alport syndrome. Nephrol Dialysis Transplantation. 2019;34:1272\u20139.","journal-title":"Nephrol Dialysis Transplantation"},{"key":"4451_CR6","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1038\/s41598-020-61250-5","volume":"10","author":"HS Choi","year":"2020","unstructured":"Choi HS, Kim IJ, Kim CS, Ma SK, Scholey JW, Kim SW, Bae EH. Angiotensin-[1\u20137] attenuates kidney injury in experimental Alport syndrome. Sci Rep. 2020;10:4225.","journal-title":"Sci Rep"},{"key":"4451_CR7","doi-asserted-by":"crossref","unstructured":"Bae EH, Kim IJ, Song JH, Choi HS, Kim CS, Eom GH, Kim I, Cha H, Cho JM, Ma SK, Kim SW. Renoprotective Effect of the Histone Deacetylase Inhibitor CG200745 in DOCA-Salt Hypertensive Rats. Int J Mol Sci. 2019:20:508.","DOI":"10.3390\/ijms20030508"},{"key":"4451_CR8","doi-asserted-by":"publisher","first-page":"11546","DOI":"10.1038\/s41598-018-30008-5","volume":"8","author":"HS Choi","year":"2018","unstructured":"Choi HS, Song JH, Kim IJ, Joo SY, Eom GH, Kim I, Cha H, Cho JM, Ma SK, Kim SW, Bae EH. Histone deacetylase inhibitor, CG200745 attenuates renal fibrosis in obstructive kidney disease. Sci Rep. 2018;8:11546.","journal-title":"Sci Rep"},{"key":"4451_CR9","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.3390\/ijms21041473","volume":"21","author":"SH Suh","year":"2020","unstructured":"Suh SH, Choi HS, Kim CS, Kim IJ, Cha H, Cho JM, Ma SK, Kim SW, Bae EH. CG200745, a Novel HDAC Inhibitor, Attenuates Kidney Fibrosis in a Murine Model of Alport Syndrome. Int J Mol Sci. 2020;21:1473.","journal-title":"Int J Mol Sci"},{"key":"4451_CR10","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.kint.2020.01.029","volume":"98","author":"VR Williams","year":"2020","unstructured":"Williams VR, Konvalinka A, Song X, Zhou X, John R, Pei Y, Scholey JW. Connectivity mapping of a chronic kidney disease progression signature identified lysine deacetylases as novel therapeutic targets. Kidney Int. 2020;98:116\u201332.","journal-title":"Kidney Int"},{"key":"4451_CR11","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1002\/ijc.34144","volume":"151","author":"JH Jo","year":"2022","unstructured":"Jo JH, Jung DE, Lee HS, Park SB, Chung MJ, Park JY, Bang S, Park SW, Cho S, Song SY. A phase I\/II study of ivaltinostat combined with gemcitabine and erlotinib in patients with untreated locally advanced or metastatic pancreatic adenocarcinoma. Int J Cancer. 2022;151:1565\u201377.","journal-title":"Int J Cancer"},{"key":"4451_CR12","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.kint.2016.12.022","volume":"91","author":"EH Bae","year":"2017","unstructured":"Bae EH, Fang F, Williams VR, Konvalinka A, Zhou X, Patel VB, Song X, John R, Oudit GY, Pei Y, Scholey JW. Murine recombinant angiotensin-converting enzyme 2 attenuates kidney injury in experimental Alport syndrome. Kidney Int. 2017;91:1347\u201361.","journal-title":"Kidney Int"},{"key":"4451_CR13","doi-asserted-by":"publisher","first-page":"F562","DOI":"10.1152\/ajprenal.2001.280.4.F562","volume":"280","author":"EI Christensen","year":"2001","unstructured":"Christensen EI, Birn H. Megalin and cubilin: synergistic endocytic receptors in renal proximal tubule. Am J Physiology-Renal Physiol. 2001;280:F562\u201373.","journal-title":"Am J Physiology-Renal Physiol"},{"key":"4451_CR14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/BF03034003","volume":"21","author":"Y-C Lin","year":"2007","unstructured":"Lin Y-C, Hung G-U, Luo T-Y, Tsai S-C, Sun S-S, Hsia C-C, Chen S-L, Lin W-Y. Reducing renal uptake of111In-DOTATOC: A comparison among various basic amino acids. Ann Nucl Med. 2007;21:79\u201383.","journal-title":"Ann Nucl Med"},{"key":"4451_CR15","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1021\/acs.bioconjchem.6b00057","volume":"27","author":"A Wischnjow","year":"2016","unstructured":"Wischnjow A, Sarko D, Janzer M, Kaufman C, Beijer B, Brings S, Haberkorn U, Larbig G, Kubelbeck A, Mier W. Renal targeting: peptide-based drug delivery to proximal tubule cells. Bioconjug Chem. 2016;27:1050\u20137.","journal-title":"Bioconjug Chem"},{"key":"4451_CR16","doi-asserted-by":"publisher","first-page":"41766","DOI":"10.1038\/s41598-025-25447-w","volume":"15","author":"K Hashikami","year":"2025","unstructured":"Hashikami K, Kobayashi R, Hori R, Danbayashi K, Nio Y. Podocyte specific exon skipping after disease onset improves kidney pathology and function in a mouse model of Alport syndrome. Sci Rep. 2025;15:41766.","journal-title":"Sci Rep"},{"key":"4451_CR17","doi-asserted-by":"crossref","unstructured":"Pavlovic N, Krizanac M, Kumric M, Vukojevic K, Bozic J. Mitochondrial Dysfunction: The Silent Catalyst of Kidney Disease Progression. Cells. 2025:14.","DOI":"10.3390\/cells14110794"},{"key":"4451_CR18","doi-asserted-by":"publisher","first-page":"119702","DOI":"10.1016\/j.biomaterials.2019.119702","volume":"232","author":"S Uthaman","year":"2020","unstructured":"Uthaman S, Pillarisetti S, Mathew AP, Kim Y, Bae WK, Huh KM, Park I-K. Long circulating photoactivable nanomicelles with tumor localized activation and ROS triggered self-accelerating drug release for enhanced locoregional chemo-photodynamic therapy. Biomaterials. 2020;232:119702.","journal-title":"Biomaterials"},{"key":"4451_CR19","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12951-022-01410-z","volume":"20","author":"HS Choi","year":"2022","unstructured":"Choi HS, Mathew AP, Uthaman S, Vasukutty A, Kim IJ, Suh SH, Kim CS, Ma SK, Graham SA, Kim SW, et al. Inflammation-sensing catalase-mimicking nanozymes alleviate acute kidney injury via reversing local oxidative stress. J Nanobiotechnol. 2022;20:205.","journal-title":"J Nanobiotechnol"},{"key":"4451_CR20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.4103\/0976-500X.119726","volume":"4","author":"J Charan","year":"2013","unstructured":"Charan J, Kantharia ND. How to calculate sample size in animal studies? J Pharmacol Pharmacother. 2013;4:303\u20136.","journal-title":"J Pharmacol Pharmacother"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04451-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04451-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04451-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T03:37:04Z","timestamp":1783568224000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04451-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4451"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04451-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8451223\/v1","asserted-by":"object"}]},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"25 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal use procedures were carried out in accordance with the Animal Care Regulations Committee of Chonnam National University Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors read and approve the final manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"631"}}